Health Condition 1: K056- Periodontal disease, unspecified
Conditions
Interventions
Intervention1: CHLORHEXIDINE IMPREGNATED PLATELET RICH FIBRIN (CHX-PRF): Chlorhexidine (CHX) has excellent efficacy and therefore has long been used in clinical practice as a local antiseptic agent. C
Sponsors
Dr. Manali S. Waghmare
Eligibility
Inclusion criteria
Inclusion criteria: 1)Participants in the age range of 18 to 65 years. 2)Participants having good oral hygiene. 3)Presence of tooth or root piece indicated for extraction. 4)Participants willingness for implant placement. 5) Participants not having any systemic health diseases or disorders. 6) Participants not having any habit of smoking or eating tobacco. 7) Participants who can afford the treatment.
Exclusion criteria
Exclusion criteria: Acute infection. Medically compromised patients. Uncooperative patients. Non-compliant patients for oral hygiene maintenance. Subjects with abnormal bleeding/clotting time. Presence of any pathology causing facial bony plate dehiscence. History of Irradiation in Head and Neck. Uncontrolled diabetic patients (reported levels of glycemia over the normal threshold) Current pregnancy or lactation. Current Smokers. Subjects with presence or history of osteonecrosis of the jaws. Subjects with use of bisphosphonates.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate and compare the differences in bone mineral density by Misch and Judy classification on CBCT (compared with standard Bone densities of respective socket regions) after four months of socket preservation during pre-operative assessment of the site for implant placement in both the groups. 2.To evaluate and compare primary stability of implants (by means of Insertion Torque Value) in both the groups. Timepoint: baseline and four months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate and compare the differences between maximum bucco-lingual width of the socket clinically (with ridge measuring pliers) and radiographically (with cone beam computed tomography [CBCT]) before tooth extraction and after four months of socket preservation with Platelet Rich Fibrin and 0.01% Chlorhexidine impregnated Platelet Rich Fibrin membrane. 2. To evaluate and compare clinical signs of inflammation around implants (peri-implant mucositis or peri-implantitis) after six months of implant placement in both the groups (according to 2017 World Workshop)18, recorded as Good, Fair and Poor. 3. To evaluate and compare radiographically peri-implant bone loss (immediately post-implant placement and six months post-implant placement) with IOPA applying long cone paralleling technique in all groups. 4. To comparatively evaluate pain scores at 24 hours in both the groups by VAS pain score. Timepoint: baseline, four months and six months and nine months. | — |
Countries
India
Contacts
Public ContactDr Manali S Waghmare
VYWS dental college and hospital
Outcome results
None listed